Serum Proteomics Profiling in Newborns: Differences Compared to Adults serum and new molecular markers for neonatal Sepsis
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Neonatal sepsis is a major cause of morbidity and mortality, particularly in low- and middle-income countries such as Senegal, where incidence is 78–104 per 1,000 live births and mortality exceeds 20 per 1,000, with case fatality rates around 36%. Diagnosis is difficult due to non-specific clinical signs and lack of molecular biomarkers, highlighting the need for improved early diagnostic molecular markers that could be applied even outside of hospital settings.
Objectives
Compare neonatal and adult serum proteomes to establish a reference and identify serum protein biomarkers of neonatal sepsis.
Methods
Serum samples from Senegalese neonates and adults were analyzed using data-independent acquisition (DIA) proteomics on neat serum (Evosep-timsTOF HT platform). The cohort comprised 6 neonates with non-confirmed sepsis (NCS), 22 with confirmed sepsis (CS), 17 healthy newborn controls (HC), 6 unclassified and 20 healthy adults. Downstream analyses included differential protein abundance testing, unsupervised clustering, weighted gene co-expression network analysis (WGCNA), and correlation analyses with clinical parameters.
Results
We identified 979±20 proteins in newborns versus 718±40 in adults. Newborns showed reduced immune-response proteins, a narrower dynamic range, and increased structural proteins such as collagens, consistent with immune immaturity and tissue development. Unsupervised WGCNA analysis led to a 53-protein cluster discriminated CS from NCS/HC. Some of these dysregulated proteins identified have already been reported in independent studies using different approaches in neonatal and/or adult sepsis. Our larger panel however of identified markers maps to three major biological processes involved in sepsis: (i) pathogen sensing (LBP, CD14), and acute-phase inflammation (e.g. CRP, SAA1/2, ORM1/2); (ii) innate immune activation and leukocyte recruitment (e.g., FCGR3A, CSF1R, CD163, CD206) and final platelet exhaustion and metabolic dysregulation, (e.g., PF4, PPBP, THBS1, GP5); (iii) endothelial injury and microvascular dysfunction with tissue remodeling (e.g., ICAM1, VCAM1, VWF, SPARC) and loss of protective lipoproteins and serpins (e.g., APOA1, APOA2, APOM, SERPINA4, SERPINA5)
Conclusion
This study provides a very comprehensive neonatal serum proteome characterization and identifies, for the first time, a protein panel of proteins mapped to three major processes in sepsis.
